Bond bubble continues—Teva sells 7-year notes @2.25%, 10-year notes @2.95%: http://finance.yahoo.com/news/teva-announces-pricing-2-0-224500399.html This is not IBM! A single product accounting for almost half of Teva’s profits—Copaxone—is going off-patent in less than 3 years.